# ResearchLens - Technical Specification
## Making Academic Research Accessible

*A platform that surfaces academic research for two audiences: the public (plain-language summaries) and VCs (investment-ready insights)*

---

## 1. THE BIG PICTURE

### What We're Building

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                           RESEARCHLENS PLATFORM                              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                  â”‚
â”‚   â”‚   DATA       â”‚    â”‚  PROCESSING  â”‚    â”‚   FRONTEND   â”‚                  â”‚
â”‚   â”‚   INGESTION  â”‚â”€â”€â”€â–¶â”‚  & SCORING   â”‚â”€â”€â”€â–¶â”‚   INTERFACES â”‚                  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                  â”‚
â”‚                                                                              â”‚
â”‚   â€¢ UCL Sources        â€¢ NLP Summaries      â€¢ Public Portal                 â”‚
â”‚   â€¢ Imperial Sources   â€¢ Topic Tagging      â€¢ VC Dashboard                  â”‚
â”‚   â€¢ UKRI Funding       â€¢ Coolness Score     â€¢ Admin Panel                   â”‚
â”‚   â€¢ Patents            â€¢ VC-Ready Score                                     â”‚
â”‚   â€¢ Altmetric                                                               â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Two User Journeys

**PUBLIC USER:** "I want to understand what cool research is happening and why it matters to me"

**VC USER:** "I want to find commercially promising research early, before competitors, with signals that help me evaluate investment potential"

---

## 2. SYSTEM ARCHITECTURE

### High-Level Architecture

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                              DATA SOURCES                                    â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ UCL         â”‚ Imperial    â”‚ UKRI GtR    â”‚ Espacenet   â”‚ Altmetric           â”‚
â”‚ Discovery   â”‚ Spiral      â”‚ (Funding)   â”‚ (Patents)   â”‚ (Social Buzz)       â”‚
â”‚ IRIS/       â”‚ Profiles    â”‚             â”‚             â”‚                     â”‚
â”‚ Profiles    â”‚             â”‚             â”‚             â”‚                     â”‚
â””â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
       â”‚             â”‚             â”‚             â”‚                 â”‚
       â–¼             â–¼             â–¼             â–¼                 â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                           INGESTION LAYER                                    â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ OAI-PMH     â”‚  â”‚ REST API    â”‚  â”‚ Web         â”‚  â”‚ Scheduled   â”‚        â”‚
â”‚  â”‚ Harvester   â”‚  â”‚ Client      â”‚  â”‚ Scraper     â”‚  â”‚ Jobs        â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                 â”‚
                                 â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                           RAW DATA STORE                                     â”‚
â”‚                         (PostgreSQL / MongoDB)                               â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”      â”‚
â”‚  â”‚ Papers   â”‚  â”‚ Research â”‚  â”‚ Patents  â”‚  â”‚ Funding  â”‚  â”‚ People   â”‚      â”‚
â”‚  â”‚          â”‚  â”‚ ers      â”‚  â”‚          â”‚  â”‚ Grants   â”‚  â”‚          â”‚      â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                 â”‚
                                 â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         PROCESSING LAYER                                     â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”‚
â”‚  â”‚ LLM Summariser  â”‚  â”‚ Topic Classifierâ”‚  â”‚ Entity Linker   â”‚              â”‚
â”‚  â”‚ (Claude API)    â”‚  â”‚ (ML Model)      â”‚  â”‚ (Match across   â”‚              â”‚
â”‚  â”‚                 â”‚  â”‚                 â”‚  â”‚  data sources)  â”‚              â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â”‚
â”‚           â”‚                    â”‚                    â”‚                        â”‚
â”‚           â–¼                    â–¼                    â–¼                        â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚                      SCORING ENGINE                              â”‚        â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”             â”‚        â”‚
â”‚  â”‚  â”‚ Public Coolness     â”‚    â”‚ VC Readiness        â”‚             â”‚        â”‚
â”‚  â”‚  â”‚ Score (0-100)       â”‚    â”‚ Score (0-100)       â”‚             â”‚        â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜             â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                 â”‚
                                 â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                        ENRICHED DATA STORE                                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚
â”‚  â”‚ Research Items (enriched)                                         â”‚       â”‚
â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                         â”‚       â”‚
â”‚  â”‚ â€¢ Original metadata (title, authors, abstract, DOI)              â”‚       â”‚
â”‚  â”‚ â€¢ Plain-language summary (for public)                            â”‚       â”‚
â”‚  â”‚ â€¢ "Why it matters" explanation                                   â”‚       â”‚
â”‚  â”‚ â€¢ Topic tags                                                     â”‚       â”‚
â”‚  â”‚ â€¢ Linked entities (researcher, grants, patents)                  â”‚       â”‚
â”‚  â”‚ â€¢ Public Coolness Score + breakdown                              â”‚       â”‚
â”‚  â”‚ â€¢ VC Readiness Score + breakdown                                 â”‚       â”‚
â”‚  â”‚ â€¢ Hot topic alignment                                            â”‚       â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                 â”‚
                                 â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                            API LAYER                                         â”‚
â”‚                         (REST / GraphQL)                                     â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”‚
â”‚  â”‚ /public/*       â”‚  â”‚ /vc/*           â”‚  â”‚ /admin/*        â”‚              â”‚
â”‚  â”‚ (no auth)       â”‚  â”‚ (auth required) â”‚  â”‚ (admin auth)    â”‚              â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                 â”‚
                                 â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                          FRONTEND LAYER                                      â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚
â”‚  â”‚   PUBLIC PORTAL     â”‚              â”‚   VC DASHBOARD      â”‚               â”‚
â”‚  â”‚   (React/Next.js)   â”‚              â”‚   (React/Next.js)   â”‚               â”‚
â”‚  â”‚                     â”‚              â”‚                     â”‚               â”‚
â”‚  â”‚ â€¢ Browse research   â”‚              â”‚ â€¢ Filter by score   â”‚               â”‚
â”‚  â”‚ â€¢ Read summaries    â”‚              â”‚ â€¢ View signals      â”‚               â”‚
â”‚  â”‚ â€¢ Explore topics    â”‚              â”‚ â€¢ Track researchers â”‚               â”‚
â”‚  â”‚ â€¢ Share stories     â”‚              â”‚ â€¢ Export lists      â”‚               â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 3. DATABASE SCHEMA

### Core Entities

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                           DATABASE SCHEMA                                    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚     RESEARCHERS     â”‚       â”‚   INSTITUTIONS      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤       â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ id                  â”‚       â”‚ id                  â”‚
â”‚ name                â”‚       â”‚ name                â”‚
â”‚ orcid               â”‚â—€â”€â”€â”€â”€â”€â”€â”‚ type (uni/company)  â”‚
â”‚ institution_id      â”‚       â”‚ website             â”‚
â”‚ department          â”‚       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚ title               â”‚
â”‚ profile_url         â”‚       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ research_interests  â”‚       â”‚   RESEARCH_ITEMS    â”‚
â”‚ h_index             â”‚       â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ created_at          â”‚       â”‚ id                  â”‚
â”‚ updated_at          â”‚       â”‚ title               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚ abstract            â”‚
         â”‚                    â”‚ doi                 â”‚
         â”‚                    â”‚ publication_date    â”‚
         â–¼                    â”‚ source (ucl/imperialâ”‚
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚        /gtr/etc)    â”‚
â”‚ RESEARCHER_ITEMS    â”‚       â”‚ source_url          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤       â”‚ type (paper/project â”‚
â”‚ researcher_id       â”‚â”€â”€â”€â”€â”€â”€â”€â”‚      /patent)       â”‚
â”‚ research_item_id    â”‚       â”‚                     â”‚
â”‚ role (author/PI)    â”‚       â”‚ â”€â”€â”€ ENRICHED â”€â”€â”€    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚ summary_public      â”‚
                              â”‚ summary_vc          â”‚
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚ why_it_matters      â”‚
â”‚      PATENTS        â”‚       â”‚ topic_tags[]        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤       â”‚                     â”‚
â”‚ id                  â”‚       â”‚ â”€â”€â”€ SCORES â”€â”€â”€      â”‚
â”‚ research_item_id    â”‚â”€â”€â”€â”€â”€â”€â”€â”‚ coolness_score      â”‚
â”‚ patent_number       â”‚       â”‚ coolness_breakdown  â”‚
â”‚ filing_date         â”‚       â”‚ vc_score            â”‚
â”‚ status              â”‚       â”‚ vc_breakdown        â”‚
â”‚ applicant           â”‚       â”‚                     â”‚
â”‚ ipc_codes[]         â”‚       â”‚ â”€â”€â”€ SIGNALS â”€â”€â”€     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚ altmetric_score     â”‚
                              â”‚ media_mentions      â”‚
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚ has_patent          â”‚
â”‚      GRANTS         â”‚       â”‚ has_industry_fundingâ”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤       â”‚ has_clinical_trial  â”‚
â”‚ id                  â”‚       â”‚ hot_topic_match     â”‚
â”‚ research_item_id    â”‚â”€â”€â”€â”€â”€â”€â”€â”‚                     â”‚
â”‚ gtr_id              â”‚       â”‚ created_at          â”‚
â”‚ funder              â”‚       â”‚ updated_at          â”‚
â”‚ amount              â”‚       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚ start_date          â”‚
â”‚ end_date            â”‚       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ is_industry_funded  â”‚       â”‚    TOPIC_TAGS       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
                              â”‚ id                  â”‚
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚ name                â”‚
â”‚   HOT_TOPICS        â”‚       â”‚ category            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤       â”‚ is_hot_topic        â”‚
â”‚ id                  â”‚       â”‚ vc_relevance_score  â”‚
â”‚ name                â”‚       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚ category            â”‚
â”‚ trend_score         â”‚
â”‚ last_updated        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 4. SCORING ALGORITHMS

### Public Coolness Score (0-100)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                      PUBLIC COOLNESS SCORE                                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  RELATABILITY (max 30 points)                                               â”‚
â”‚  â”œâ”€â”€ Health/Medicine topic?                    +10                          â”‚
â”‚  â”œâ”€â”€ Climate/Environment topic?                +10                          â”‚
â”‚  â”œâ”€â”€ AI/Technology topic?                      +10                          â”‚
â”‚  â”œâ”€â”€ Food/Agriculture topic?                   +5                           â”‚
â”‚  â””â”€â”€ Affects daily life? (NLP detect)          +5                           â”‚
â”‚                                                                              â”‚
â”‚  UNDERSTANDABILITY (max 30 points)                                          â”‚
â”‚  â”œâ”€â”€ Flesch-Kincaid readability > 50           +15                          â”‚
â”‚  â”œâ”€â”€ Abstract length < 200 words               +5                           â”‚
â”‚  â”œâ”€â”€ Jargon density < 10%                      +10                          â”‚
â”‚  â””â”€â”€ Has visual outputs (images/video)         +5                           â”‚
â”‚                                                                              â”‚
â”‚  WOW FACTOR (max 40 points)                                                 â”‚
â”‚  â”œâ”€â”€ Altmetric score > 50th percentile         +10                          â”‚
â”‚  â”œâ”€â”€ Altmetric score > 90th percentile         +10 (additional)             â”‚
â”‚  â”œâ”€â”€ Media coverage exists                     +10                          â”‚
â”‚  â”œâ”€â”€ "First/Novel/Breakthrough" in title       +5                           â”‚
â”‚  â””â”€â”€ Social media engagement                   +5                           â”‚
â”‚                                                                              â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•                                â”‚
â”‚  TOTAL: Sum of above, capped at 100                                         â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### VC Readiness Score (0-100)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                        VC READINESS SCORE                                    â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  IP & COMMERCIAL SIGNALS (max 40 points)                                    â”‚
â”‚  â”œâ”€â”€ Patent filed                              +20                          â”‚
â”‚  â”œâ”€â”€ Patent granted                            +10 (additional)             â”‚
â”‚  â”œâ”€â”€ Industry co-funding on grant              +10                          â”‚
â”‚  â”œâ”€â”€ Spin-out company exists                   +10                          â”‚
â”‚  â””â”€â”€ Licensing agreement mentioned             +5                           â”‚
â”‚                                                                              â”‚
â”‚  STAGE & TRACTION (max 30 points)                                           â”‚
â”‚  â”œâ”€â”€ Clinical trial registered                 +15                          â”‚
â”‚  â”œâ”€â”€ Phase 2+ clinical trial                   +10 (additional)             â”‚
â”‚  â”œâ”€â”€ Follow-on grants (2+ grants)              +10                          â”‚
â”‚  â”œâ”€â”€ Grant size > Â£500K                        +5                           â”‚
â”‚  â”œâ”€â”€ Grant size > Â£2M                          +5 (additional)              â”‚
â”‚  â””â”€â”€ Multiple institutional collaborators      +5                           â”‚
â”‚                                                                              â”‚
â”‚  HOT TOPIC ALIGNMENT (max 30 points)                                        â”‚
â”‚  â”œâ”€â”€ Matches top VC theme (AI, biotech, etc)   +15                          â”‚
â”‚  â”œâ”€â”€ Rising trend (Google Trends +)            +10                          â”‚
â”‚  â””â”€â”€ Recent VC deals in space (Crunchbase)     +5                           â”‚
â”‚                                                                              â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•                                â”‚
â”‚  TOTAL: Sum of above, capped at 100                                         â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 5. DATA PIPELINE

### Ingestion Flow

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         DATA INGESTION PIPELINE                              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  DAILY JOBS                                                                  â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ 1. Harvest OAI-PMH (UCL Discovery, Spiral)                       â”‚        â”‚
â”‚  â”‚    â””â”€â”€ Get new/updated records since last harvest                â”‚        â”‚
â”‚  â”‚                                                                   â”‚        â”‚
â”‚  â”‚ 2. Poll Altmetric API                                            â”‚        â”‚
â”‚  â”‚    â””â”€â”€ Update social/media scores for existing items             â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                                                                              â”‚
â”‚  WEEKLY JOBS                                                                 â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                                 â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ 3. Scrape researcher profiles (UCL Profiles, Imperial Profiles)  â”‚        â”‚
â”‚  â”‚    â””â”€â”€ Update researcher metadata, new publications              â”‚        â”‚
â”‚  â”‚                                                                   â”‚        â”‚
â”‚  â”‚ 4. Query UKRI Gateway to Research API                            â”‚        â”‚
â”‚  â”‚    â””â”€â”€ Get new grants, update existing grant outcomes            â”‚        â”‚
â”‚  â”‚                                                                   â”‚        â”‚
â”‚  â”‚ 5. Search Espacenet for new patents                              â”‚        â”‚
â”‚  â”‚    â””â”€â”€ Match by researcher name / institution                    â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                                                                              â”‚
â”‚  MONTHLY JOBS                                                                â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ 6. Update hot topics list                                        â”‚        â”‚
â”‚  â”‚    â””â”€â”€ Pull from Crunchbase, Google Trends, manual curation      â”‚        â”‚
â”‚  â”‚                                                                   â”‚        â”‚
â”‚  â”‚ 7. Full re-scrape of department pages                            â”‚        â”‚
â”‚  â”‚    â””â”€â”€ Catch new research groups, structural changes             â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Processing Flow

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                        PROCESSING PIPELINE                                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  For each new/updated Research Item:                                        â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ STEP 1: ENTITY LINKING                                           â”‚        â”‚
â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                            â”‚        â”‚
â”‚  â”‚ â€¢ Match authors to Researcher records (by ORCID, name fuzzy)     â”‚        â”‚
â”‚  â”‚ â€¢ Link to existing Grants (by PI name, project title similarity) â”‚        â”‚
â”‚  â”‚ â€¢ Link to Patents (by inventor name, abstract similarity)        â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                           â”‚                                                  â”‚
â”‚                           â–¼                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ STEP 2: TOPIC CLASSIFICATION                                     â”‚        â”‚
â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                      â”‚        â”‚
â”‚  â”‚ â€¢ Run abstract through topic classifier (fine-tuned BERT or LLM) â”‚        â”‚
â”‚  â”‚ â€¢ Assign top 3 topic tags                                        â”‚        â”‚
â”‚  â”‚ â€¢ Flag if matches any "hot topic"                                â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                           â”‚                                                  â”‚
â”‚                           â–¼                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ STEP 3: LLM SUMMARISATION (Claude API)                           â”‚        â”‚
â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                            â”‚        â”‚
â”‚  â”‚                                                                   â”‚        â”‚
â”‚  â”‚ Prompt for PUBLIC summary:                                        â”‚        â”‚
â”‚  â”‚ "Summarise this research in 2-3 sentences that a curious         â”‚        â”‚
â”‚  â”‚  teenager could understand. Avoid jargon. Focus on what was      â”‚        â”‚
â”‚  â”‚  discovered and why it's interesting."                           â”‚        â”‚
â”‚  â”‚                                                                   â”‚        â”‚
â”‚  â”‚ Prompt for "WHY IT MATTERS":                                     â”‚        â”‚
â”‚  â”‚ "In 1-2 sentences, explain how this research could affect        â”‚        â”‚
â”‚  â”‚  people's lives in the future. Be specific and concrete."        â”‚        â”‚
â”‚  â”‚                                                                   â”‚        â”‚
â”‚  â”‚ Prompt for VC summary:                                            â”‚        â”‚
â”‚  â”‚ "Summarise the commercial potential of this research in 2-3      â”‚        â”‚
â”‚  â”‚  sentences. Focus on: problem being solved, novelty of approach, â”‚        â”‚
â”‚  â”‚  potential applications, and market opportunity."                â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                           â”‚                                                  â”‚
â”‚                           â–¼                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ STEP 4: SCORING                                                  â”‚        â”‚
â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                   â”‚        â”‚
â”‚  â”‚ â€¢ Calculate Public Coolness Score (see algorithm above)          â”‚        â”‚
â”‚  â”‚ â€¢ Calculate VC Readiness Score (see algorithm above)             â”‚        â”‚
â”‚  â”‚ â€¢ Store score breakdowns for transparency                        â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                           â”‚                                                  â”‚
â”‚                           â–¼                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ STEP 5: SAVE ENRICHED RECORD                                     â”‚        â”‚
â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                     â”‚        â”‚
â”‚  â”‚ â€¢ Write to enriched data store                                   â”‚        â”‚
â”‚  â”‚ â€¢ Update search index (Elasticsearch/Algolia)                    â”‚        â”‚
â”‚  â”‚ â€¢ Trigger notifications if score thresholds met                  â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 6. FRONTEND SPECIFICATIONS

### 6.1 Public Portal

#### Homepage

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”¬ ResearchLens                                    [Search] [Topics] [About]â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚
â”‚     â”‚                                                                â”‚       â”‚
â”‚     â”‚         Discover Groundbreaking Research                      â”‚       â”‚
â”‚     â”‚         from London's Top Universities                        â”‚       â”‚
â”‚     â”‚                                                                â”‚       â”‚
â”‚     â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚       â”‚
â”‚     â”‚    â”‚  ğŸ”  Search research topics...                       â”‚    â”‚       â”‚
â”‚     â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚       â”‚
â”‚     â”‚                                                                â”‚       â”‚
â”‚     â”‚    Popular: [AI] [Cancer] [Climate] [Brain] [Robotics]        â”‚       â”‚
â”‚     â”‚                                                                â”‚       â”‚
â”‚     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚     ğŸ”¥ TRENDING THIS WEEK                                                   â”‚
â”‚     â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                   â”‚
â”‚                                                                              â”‚
â”‚     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚     â”‚ [IMAGE]             â”‚  â”‚ [IMAGE]             â”‚  â”‚ [IMAGE]         â”‚   â”‚
â”‚     â”‚                     â”‚  â”‚                     â”‚  â”‚                 â”‚   â”‚
â”‚     â”‚ Scientists discover â”‚  â”‚ New AI model can    â”‚  â”‚ Breakthrough in â”‚   â”‚
â”‚     â”‚ high blood pressure â”‚  â”‚ predict diseases    â”‚  â”‚ solar cell      â”‚   â”‚
â”‚     â”‚ drug could slow     â”‚  â”‚ 5 years before      â”‚  â”‚ efficiency      â”‚   â”‚
â”‚     â”‚ Alzheimer's         â”‚  â”‚ symptoms appear     â”‚  â”‚                 â”‚   â”‚
â”‚     â”‚                     â”‚  â”‚                     â”‚  â”‚                 â”‚   â”‚
â”‚     â”‚ UCL â€¢ Neuroscience  â”‚  â”‚ Imperial â€¢ AI       â”‚  â”‚ Imperial â€¢      â”‚   â”‚
â”‚     â”‚                     â”‚  â”‚                     â”‚  â”‚ Materials       â”‚   â”‚
â”‚     â”‚ [Read More â†’]       â”‚  â”‚ [Read More â†’]       â”‚  â”‚ [Read More â†’]   â”‚   â”‚
â”‚     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚     ğŸ“š BROWSE BY TOPIC                                                      â”‚
â”‚     â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                      â”‚
â”‚                                                                              â”‚
â”‚     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚
â”‚     â”‚ ğŸ§¬       â”‚ â”‚ ğŸ§        â”‚ â”‚ ğŸŒ       â”‚ â”‚ ğŸ¤–       â”‚ â”‚ ğŸ’Š       â”‚       â”‚
â”‚     â”‚ Genetics â”‚ â”‚ Brain &  â”‚ â”‚ Climate  â”‚ â”‚ AI &     â”‚ â”‚ Drug     â”‚       â”‚
â”‚     â”‚          â”‚ â”‚ Mind     â”‚ â”‚          â”‚ â”‚ Robots   â”‚ â”‚ Discoveryâ”‚       â”‚
â”‚     â”‚ 234 itemsâ”‚ â”‚ 189 itemsâ”‚ â”‚ 156 itemsâ”‚ â”‚ 312 itemsâ”‚ â”‚ 267 itemsâ”‚       â”‚
â”‚     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Research Item Detail (Public View)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”¬ ResearchLens                                    [Search] [Topics] [About]â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  â† Back to results                                                          â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  [ğŸ§  NEUROSCIENCE]  [ğŸ”¬ DRUG DISCOVERY]                               â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”   â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  Scientists Find Blood Pressure Drug Could                            â”‚  â”‚
â”‚  â”‚  Slow Alzheimer's Disease Progression                                 â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”   â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  UCL Queen Square Institute of Neurology                              â”‚  â”‚
â”‚  â”‚  Published: January 2026                                              â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚                                          â”‚  â”‚                           â”‚ â”‚
â”‚  â”‚  ğŸ“– THE SIMPLE VERSION                   â”‚  â”‚  ğŸ‘¤ LEAD RESEARCHER       â”‚ â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                   â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚ â”‚
â”‚  â”‚                                          â”‚  â”‚                           â”‚ â”‚
â”‚  â”‚  Researchers at UCL found that a common  â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”                  â”‚ â”‚
â”‚  â”‚  medication already used to treat high   â”‚  â”‚  â”‚photoâ”‚ Prof. Jane Smith â”‚ â”‚
â”‚  â”‚  blood pressure might help slow down     â”‚  â”‚  â””â”€â”€â”€â”€â”€â”˜                  â”‚ â”‚
â”‚  â”‚  Alzheimer's disease. In tests with      â”‚  â”‚  UCL Dementia Research    â”‚ â”‚
â”‚  â”‚  patients, those taking the drug showed  â”‚  â”‚  Centre                   â”‚ â”‚
â”‚  â”‚  30% less brain shrinkage over two       â”‚  â”‚                           â”‚ â”‚
â”‚  â”‚  years compared to those who didn't.     â”‚  â”‚  [View Profile â†’]         â”‚ â”‚
â”‚  â”‚                                          â”‚  â”‚                           â”‚ â”‚
â”‚  â”‚                                          â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤ â”‚
â”‚  â”‚  ğŸ’¡ WHY IT MATTERS                       â”‚  â”‚                           â”‚ â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                       â”‚  â”‚  ğŸ“Š RESEARCH SIGNALS      â”‚ â”‚
â”‚  â”‚                                          â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚ â”‚
â”‚  â”‚  Alzheimer's affects 1 million people    â”‚  â”‚                           â”‚ â”‚
â”‚  â”‚  in the UK. Because this drug is already â”‚  â”‚  âœ“ Funded by Wellcome     â”‚ â”‚
â”‚  â”‚  approved and safe, it could be          â”‚  â”‚  âœ“ 45 news mentions       â”‚ â”‚
â”‚  â”‚  available to patients much faster than  â”‚  â”‚  âœ“ Clinical trial active  â”‚ â”‚
â”‚  â”‚  a brand new treatmentâ€”potentially       â”‚  â”‚  âœ“ Â£2.3M grant funding    â”‚ â”‚
â”‚  â”‚  helping millions within a few years.    â”‚  â”‚                           â”‚ â”‚
â”‚  â”‚                                          â”‚  â”‚                           â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  ğŸ“„ ORIGINAL RESEARCH                                                  â”‚  â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                  â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  "Amlodipine and brain atrophy in Alzheimer's disease: a randomised   â”‚  â”‚
â”‚  â”‚   controlled trial"                                                    â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  Published in: The Lancet Neurology                                   â”‚  â”‚
â”‚  â”‚  DOI: 10.1016/S1474-4422(26)00012-3                                   â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  [Read Full Paper â†—]  [View on UCL Discovery â†—]                       â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚  ğŸ”— SHARE THIS RESEARCH                                                     â”‚
â”‚                                                                              â”‚
â”‚  [Twitter] [LinkedIn] [Facebook] [Copy Link]                                â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 6.2 VC Dashboard

#### VC Homepage / Search

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ResearchLens PRO                           [Dashboard] [Saved] [Settings]  â”‚
â”‚  For Investors                                              Welcome, Sarah  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  ğŸ” Search research, researchers, or topics...                        â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ FILTERS                                                              â”‚    â”‚
â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€                                                              â”‚    â”‚
â”‚  â”‚                                                                       â”‚    â”‚
â”‚  â”‚ VC Score:     [â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘] 70+                                       â”‚    â”‚
â”‚  â”‚                                                                       â”‚    â”‚
â”‚  â”‚ Stage:        [x] Has Patent  [x] Has Grant  [ ] Clinical Trial      â”‚    â”‚
â”‚  â”‚                                                                       â”‚    â”‚
â”‚  â”‚ Hot Topics:   [x] AI/ML  [x] Biotech  [ ] Climate  [ ] Robotics      â”‚    â”‚
â”‚  â”‚                                                                       â”‚    â”‚
â”‚  â”‚ Institution:  [x] UCL  [x] Imperial  [ ] Other                       â”‚    â”‚
â”‚  â”‚                                                                       â”‚    â”‚
â”‚  â”‚ Time:         [Last 6 months â–¼]                                      â”‚    â”‚
â”‚  â”‚                                                                       â”‚    â”‚
â”‚  â”‚ [Apply Filters]  [Clear All]  [Save as Alert]                        â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚  ğŸ“Š RESULTS (47 matches)                              Sort: [VC Score â–¼]    â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                    â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  VC SCORE                                                             â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”                                                               â”‚  â”‚
â”‚  â”‚  â”‚ 94 â”‚  Novel CAR-T Manufacturing Platform Reduces Cost by 80%      â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”˜                                                               â”‚  â”‚
â”‚  â”‚          Imperial â€¢ Bioengineering â€¢ Prof. Michael Chen              â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  SIGNALS:  ğŸ”· Patent Filed  ğŸ”· Â£3.2M UKRI Grant  ğŸ”· Industry Partner  â”‚  â”‚
â”‚  â”‚            ğŸ”¥ Matches: Cell Therapy, Manufacturing                    â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  "Platform technology enabling automated, closed-system CAR-T        â”‚  â”‚
â”‚  â”‚   production at 1/5th current cost. Addresses key bottleneck in      â”‚  â”‚
â”‚  â”‚   cell therapy manufacturing scalability."                           â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  [View Details]  [Save]  [Contact Researcher]                        â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  VC SCORE                                                             â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”                                                               â”‚  â”‚
â”‚  â”‚  â”‚ 89 â”‚  AI Model Predicts Drug-Drug Interactions with 97% Accuracy  â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”˜                                                               â”‚  â”‚
â”‚  â”‚          UCL â€¢ Computer Science â€¢ Dr. Sarah Patel                    â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  SIGNALS:  ğŸ”· Patent Pending  ğŸ”· Pharma Co-funding  ğŸ”· 2nd Grant      â”‚  â”‚
â”‚  â”‚            ğŸ”¥ Matches: AI Drug Discovery, Clinical AI                 â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  "Machine learning system that predicts adverse drug interactions    â”‚  â”‚
â”‚  â”‚   from molecular structure. Potential to reduce drug trial failures  â”‚  â”‚
â”‚  â”‚   and accelerate approval timelines."                                â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  [View Details]  [Save]  [Contact Researcher]                        â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                              â”‚
â”‚  [Load More Results...]                                                     â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### VC Research Detail View

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ResearchLens PRO                           [Dashboard] [Saved] [Settings]  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  â† Back to results                                      [Save] [Export PDF] â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”                                                          â”‚  â”‚
â”‚  â”‚  â”‚VC SCORE â”‚   Novel CAR-T Manufacturing Platform                     â”‚  â”‚
â”‚  â”‚  â”‚         â”‚   Reduces Production Cost by 80%                         â”‚  â”‚
â”‚  â”‚  â”‚   94    â”‚                                                          â”‚  â”‚
â”‚  â”‚  â”‚         â”‚   Imperial College London â€¢ Dept of Bioengineering       â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                                                          â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚                                  â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚  ğŸ“Š SCORE BREAKDOWN              â”‚  â”‚  ğŸ¯ HOT TOPIC ALIGNMENT           â”‚ â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€              â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€            â”‚ â”‚
â”‚  â”‚                                  â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚  IP & Commercial      35/40     â”‚  â”‚  Cell & Gene Therapy    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚ â”‚
â”‚  â”‚  â”œâ”€ Patent filed        +20     â”‚  â”‚  Manufacturing          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â”‚ â”‚
â”‚  â”‚  â”œâ”€ Industry funding    +10     â”‚  â”‚  Bioprocessing          â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ     â”‚ â”‚
â”‚  â”‚  â””â”€ Licensing talks      +5     â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚                                  â”‚  â”‚  Recent VC deals in space:       â”‚ â”‚
â”‚  â”‚  Stage & Traction     29/30     â”‚  â”‚  â€¢ Cellares ($255M, 2025)         â”‚ â”‚
â”‚  â”‚  â”œâ”€ Grant > Â£2M         +10     â”‚  â”‚  â€¢ ElevateBio ($525M, 2024)       â”‚ â”‚
â”‚  â”‚  â”œâ”€ Follow-on grant     +10     â”‚  â”‚  â€¢ Ori Biotech ($100M, 2024)      â”‚ â”‚
â”‚  â”‚  â”œâ”€ Multi-institution    +5     â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚  â””â”€ Phase 1 trial        +4     â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚                                  â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚  Hot Topic             30/30    â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚  â”œâ”€ Top VC theme        +15     â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚  â”œâ”€ Rising trend        +10     â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚  â””â”€ Recent deals         +5     â”‚  â”‚                                   â”‚ â”‚
â”‚  â”‚                                  â”‚  â”‚                                   â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  ğŸ’¼ COMMERCIAL SUMMARY                                                â”‚  â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  Platform technology enabling automated, closed-system CAR-T cell     â”‚  â”‚
â”‚  â”‚  manufacturing at approximately 1/5th the cost of current methods.    â”‚  â”‚
â”‚  â”‚  Addresses the primary bottleneck in cell therapy scalabilityâ€”        â”‚  â”‚
â”‚  â”‚  manufacturing complexity and cost ($300-500K per patient today).     â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  The system uses novel bioreactor design combined with AI-driven      â”‚  â”‚
â”‚  â”‚  process control to reduce manual interventions by 90% while          â”‚  â”‚
â”‚  â”‚  improving cell yield consistency. Early partnership discussions      â”‚  â”‚
â”‚  â”‚  with two top-10 pharma companies.                                    â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  Market opportunity: Global CAR-T market projected at $20B by 2030.   â”‚  â”‚
â”‚  â”‚  Manufacturing costs represent 40-60% of therapy cost.                â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚                                â”‚  â”‚                                     â”‚ â”‚
â”‚  â”‚  ğŸ‘¤ LEAD RESEARCHER            â”‚  â”‚  ğŸ“‹ LINKED ASSETS                   â”‚ â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€            â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                    â”‚ â”‚
â”‚  â”‚                                â”‚  â”‚                                     â”‚ â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â” Prof. Michael Chen   â”‚  â”‚  PATENTS                            â”‚ â”‚
â”‚  â”‚  â”‚photoâ”‚                       â”‚  â”‚  â”œâ”€ GB2612345 "Automated cell..."  â”‚ â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”˜ Chair of Bioprocess  â”‚  â”‚  â””â”€ PCT/GB2025/... (pending)        â”‚ â”‚
â”‚  â”‚          Engineering           â”‚  â”‚                                     â”‚ â”‚
â”‚  â”‚                                â”‚  â”‚  GRANTS                             â”‚ â”‚
â”‚  â”‚  h-index: 47                   â”‚  â”‚  â”œâ”€ UKRI Â£3.2M (2024-2027)         â”‚ â”‚
â”‚  â”‚  Patents: 12                   â”‚  â”‚  â””â”€ Innovate UK Â£800K (2023-24)    â”‚ â”‚
â”‚  â”‚  Spin-outs: 2                  â”‚  â”‚                                     â”‚ â”‚
â”‚  â”‚                                â”‚  â”‚  CLINICAL TRIALS                    â”‚ â”‚
â”‚  â”‚  Prior exits:                  â”‚  â”‚  â””â”€ NCT05XXXXXX (Phase 1)          â”‚ â”‚
â”‚  â”‚  â€¢ CellTech (acq. Â£45M, 2019) â”‚  â”‚                                     â”‚ â”‚
â”‚  â”‚                                â”‚  â”‚  PUBLICATIONS                       â”‚ â”‚
â”‚  â”‚  [Full Profile â†’]              â”‚  â”‚  â””â”€ 8 related papers (2022-2026)   â”‚ â”‚
â”‚  â”‚                                â”‚  â”‚                                     â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  ğŸ“„ SOURCE PUBLICATIONS                                               â”‚  â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                               â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  1. "Scalable closed-system bioreactor for CAR-T manufacturing"      â”‚  â”‚
â”‚  â”‚     Nature Biotechnology, 2025 â€¢ DOI: 10.1038/s41587-025-xxxxx       â”‚  â”‚
â”‚  â”‚     [View Paper â†—]                                                    â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â”‚  2. "AI-driven process control in cell therapy production"           â”‚  â”‚
â”‚  â”‚     Cell Reports Methods, 2024 â€¢ DOI: 10.1016/j.crmeth.2024.xxxxx   â”‚  â”‚
â”‚  â”‚     [View Paper â†—]                                                    â”‚  â”‚
â”‚  â”‚                                                                        â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚  [ğŸ’¾ Save to List]  [ğŸ“§ Contact Researcher]  [ğŸ“¤ Export PDF]  [ğŸ”— Share]   â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 7. TECHNOLOGY STACK RECOMMENDATIONS

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         RECOMMENDED TECH STACK                               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  BACKEND                                                                     â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€                                                                     â”‚
â”‚  â€¢ Language:        Python 3.11+ (data processing) + Node.js (API)          â”‚
â”‚  â€¢ Framework:       FastAPI (Python) or Express (Node)                      â”‚
â”‚  â€¢ Database:        PostgreSQL (main) + Redis (caching)                     â”‚
â”‚  â€¢ Search:          Elasticsearch or Algolia                                â”‚
â”‚  â€¢ Task Queue:      Celery + Redis (for scraping/processing jobs)           â”‚
â”‚  â€¢ LLM:             Anthropic Claude API (summarisation)                    â”‚
â”‚                                                                              â”‚
â”‚  FRONTEND                                                                    â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€                                                                    â”‚
â”‚  â€¢ Framework:       Next.js 14+ (React)                                     â”‚
â”‚  â€¢ Styling:         Tailwind CSS                                            â”‚
â”‚  â€¢ State:           React Query (server state) + Zustand (client)           â”‚
â”‚  â€¢ Charts:          Recharts or D3.js                                       â”‚
â”‚                                                                              â”‚
â”‚  INFRASTRUCTURE                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                              â”‚
â”‚  â€¢ Hosting:         Vercel (frontend) + Railway/Render (backend)            â”‚
â”‚  â€¢ Or:              AWS (EC2/ECS + RDS + ElastiCache)                       â”‚
â”‚  â€¢ CDN:             Cloudflare                                              â”‚
â”‚  â€¢ Monitoring:      Sentry (errors) + PostHog (analytics)                   â”‚
â”‚                                                                              â”‚
â”‚  DATA INGESTION                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                              â”‚
â”‚  â€¢ OAI-PMH:         Sickle (Python library)                                 â”‚
â”‚  â€¢ Web Scraping:    Scrapy or Playwright                                    â”‚
â”‚  â€¢ APIs:            httpx (Python) with rate limiting                       â”‚
â”‚                                                                              â”‚
â”‚  EXTERNAL APIS                                                               â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                               â”‚
â”‚  â€¢ Altmetric API:   Free tier available                                     â”‚
â”‚  â€¢ UKRI GtR API:    Free, no auth required                                  â”‚
â”‚  â€¢ Espacenet:       Free, bulk download available                           â”‚
â”‚  â€¢ Claude API:      Pay per token (for summaries)                           â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 8. DEVELOPMENT PHASES

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         DEVELOPMENT ROADMAP                                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                              â”‚
â”‚  PHASE 1: MVP (4-6 weeks)                                                   â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•                                                   â”‚
â”‚  â–¡ Set up database schema                                                   â”‚
â”‚  â–¡ Build OAI-PMH harvester (UCL Discovery + Spiral)                        â”‚
â”‚  â–¡ Basic topic classification (keyword matching)                            â”‚
â”‚  â–¡ Claude API integration for summaries                                     â”‚
â”‚  â–¡ Simple scoring algorithm (v1)                                            â”‚
â”‚  â–¡ Public portal: homepage + detail page                                    â”‚
â”‚  â–¡ Basic search functionality                                               â”‚
â”‚                                                                              â”‚
â”‚  DELIVERABLE: Public can browse and read simplified research summaries     â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚  PHASE 2: VC Features (4-6 weeks)                                           â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•                                           â”‚
â”‚  â–¡ User authentication (VC accounts)                                        â”‚
â”‚  â–¡ GtR API integration (funding data)                                       â”‚
â”‚  â–¡ Patent matching (Espacenet)                                              â”‚
â”‚  â–¡ VC scoring algorithm                                                     â”‚
â”‚  â–¡ VC dashboard with filters                                                â”‚
â”‚  â–¡ VC detail view with score breakdown                                      â”‚
â”‚  â–¡ Save/bookmark functionality                                              â”‚
â”‚                                                                              â”‚
â”‚  DELIVERABLE: VCs can filter and evaluate research opportunities           â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚  PHASE 3: Enrichment (4-6 weeks)                                            â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•                                            â”‚
â”‚  â–¡ Altmetric API integration                                                â”‚
â”‚  â–¡ Researcher profile scraping                                              â”‚
â”‚  â–¡ Entity linking (authors â†” grants â†” patents)                             â”‚
â”‚  â–¡ Hot topics tracking system                                               â”‚
â”‚  â–¡ Improved ML-based topic classification                                   â”‚
â”‚  â–¡ Email alerts for saved searches                                          â”‚
â”‚                                                                              â”‚
â”‚  DELIVERABLE: Richer data, better scoring, proactive notifications         â”‚
â”‚                                                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                                                                              â”‚
â”‚  PHASE 4: Scale & Polish (ongoing)                                          â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•                                          â”‚
â”‚  â–¡ Add more universities                                                    â”‚
â”‚  â–¡ Performance optimization                                                 â”‚
â”‚  â–¡ Mobile app                                                               â”‚
â”‚  â–¡ API for partners                                                         â”‚
â”‚  â–¡ Premium features                                                         â”‚
â”‚                                                                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 9. KEY API ENDPOINTS

```
PUBLIC API
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
GET  /api/public/research                    # List research (paginated, filtered)
GET  /api/public/research/:id                # Single research item
GET  /api/public/topics                      # List all topics
GET  /api/public/topics/:slug                # Research by topic
GET  /api/public/search?q=...                # Search

VC API (authenticated)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
GET  /api/vc/research                        # List with VC scores
GET  /api/vc/research/:id                    # Full VC detail view
GET  /api/vc/researchers/:id                 # Researcher profile
GET  /api/vc/saved                           # User's saved items
POST /api/vc/saved                           # Save an item
GET  /api/vc/alerts                          # User's search alerts
POST /api/vc/alerts                          # Create alert
GET  /api/vc/export/:id                      # Export as PDF

ADMIN API
â”€â”€â”€â”€â”€â”€â”€â”€â”€
POST /api/admin/ingest/trigger               # Manually trigger ingestion
GET  /api/admin/stats                        # Platform statistics
PUT  /api/admin/hot-topics                   # Update hot topics list
```

---

## 10. QUESTIONS FOR DISCUSSION

Before starting development, decide:

1. **Scope:** Start with just UCL + Imperial, or include others from day 1?

2. **Auth:** Do VCs need to register/pay, or start with free access?

3. **Summaries:** Generate all summaries upfront, or on-demand (cost trade-off)?

4. **Hot topics:** Manually curated list, or attempt to automate from VC news?

5. **Contact researchers:** Build in-app messaging, or just link to university profiles?

6. **Mobile:** Web-responsive first, or native apps needed?

---

*Document Version: 1.0*
*Created: February 2026*
*For: ResearchLens Platform Development*
